drugset / Trial / NCT01611883

A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

NCT01611883

Phase 4 Completed 152 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will examine the effect of ezetimibe on glucose metabolism in participants with Type 2 diabetes and hypercholesterolemia.The primary hypothesis is that change in glycated hemoglobin (HbA1c) from baseline in the ezetimibe treatment group will be non-inferior to the placebo control group.

Timeline

Start
2012-07-02
Primary completion
2014-01-16
Completion
2014-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg Oral

Indications

No indication recorded.